Upload
others
View
1
Download
0
Embed Size (px)
Citation preview
v
Attracting Talent &
Driving Growth in Wisconsin
2nd Annual Future Wisconsin
Economic Summit
Kevin Conroy, Chairman & CEO
December 9, 2015
Exact Sciences’ progress and growth since 2009
Pillars of Wisconsin’s long-term prosperity
Importance of entrepreneurship in Wisconsin
WMC Foundation: Second Annual
Future Wisconsin Economic Summit Why is Wisconsin’s high-tech industry critical to our growth?
2
Exact Sciences' progress and growth since 2009
3
To work with patients, payers and providers to help play a role in the
eradication of colorectal cancer
OUR FIRST
MISSION
Jamie
Truesdell
Wendy
Finch
4
Sources:
ACS Cancer Facts & Figures 2015; all figures annual
J Natl Cancer Inst. 2011; 103:1-12 (Mariotto)
Our challenge: eradicating the second deadliest cancer
new diagnoses in 2015
15,590
27,540
40,560 40,730
49,700
158,040
Esophageal Prostate Pancreas Breast Colorectal Lung
Annual US cancer mortality
$20B Projected annual U.S. spending
on colon cancer treatment
#2 cancer killer
5
Sources: J Natl Cancer Inst. 2009; 101:1225-1227 (Itzkowitz)
N Engl J Med 2012;366:687-96 (Zauber);
Gastro 1997;112:594-692 (Winawer)
Why is colon cancer the most preventable cancer?
Pre-cancerous polyp Four stages of
colon cancer
10+
years
6
Source: SEER 18 2004-2010
Detecting colorectal cancer early is important
9 out of 10 Survive 5 years
1 out of 10 Survive 5 years
Diagnosed in Stages I or II Diagnosed in Stage IV
7
America’s stagnated colon cancer screening rate
50.0% 52.1% 58.6% 58.2%
80.0% 80.0%
2005 2008 2010 2013 2018 2020
8
A cutting edge non-invasive test with
a lab focused on compliance
7 DNA mutation
2 DNA methylation
1 Hemoglobin
1 Beta-actin
Cologuard®
at-home sDNA testing
Exact Sciences Labs
compliance program
+
9
Source: Imperiale TF et al. N Engl J Med. 2014;370(14):1287-1297
Cologuard’s® performance in a 10,000 patient study
Developing a world-class lab to deliver results
Capable of processing more than 1 million Cologuard® tests per year
11
*Patient compliance rate: number of valid test results reported divided by the number of collection kits shipped to patients 60 or more days prior to September 30, 2015.
Cologuard’s® comprehensive screening program
driving compliance
73% Patient
Compliance*
Physician
orders
Customer
outreach
Cologuard
completed
Physician
provided
result
12
Cologuard’s® U.S. market opportunity
80M people
$3B U.S. opportunity
13
Aug 2014 Sep Oct Nov Dec Jan Feb Mar Apr May Jun Jul Aug Sep
Physicians ordering Cologuard® continues expanding
• ~500 new physicians order Cologuard weekly
Q4 2014
Q1 2015 Q2 2015 Q3 2015
4,100
8,300
14,700
21,000
14
Completed Cologuard® tests continues growing
4K
11K
21K
34K
>42K
>240K
Q4 2014 Q1 2015 Q2 2015 Q3 2015 Q4 2015 2016
Completed Cologuard Tests
Guidance Guidance
15
Increasing America’s screening population (ages 50 -74)
49% screened with
colonoscopy
Screening history of Cologuard® users
42% never
screened before
Source: Colorectal Cancer Screening with Multi-target stool DNA-based Testing Previous Screening History of the Initial Patient Cohort, poster presented at
American College of Gastroenterology's Annual Scientific Meeting (ACG 2015), Oct. 16-21, 2015
9% screened only
with FIT/FOBT
16
Building and retaining high-quality talent
3 35 61 87
102
409
719
2009 2010 2011 2012 2013 2014 2015
Exact Sciences employee growth since moving to Madison
17
18
Broad skillset across Wisconsin-based team
Breakdown of Exact Sciences 400+ team members by function
Lab 80
Customer care center 90
Finance, accounting & billing 50
Operations & manufacturing 50
Sales & marketing 45
Research & development 65
Source: Results of the 2015 Great Workplace Award Recipients &
participation in the Gallup Q12 Engagement Survey (2015)
Mission-driven, engaged team
2015 employee engagement index1: ranks in line with Gallup’s World Class Clients
0%
“The mission or
purpose of the
company makes me
feel my job is
important”
“My team members are
committed to doing
quality work”
“This last year, I have
had opportunities at
work to learn and
grow”
Exact Sciences’
percentile rank
compared to
Gallup database
99th 98th 92nd
0% 100% 0% 100% 0% 100%
19
Importance of entrepreneurship in Wisconsin
20
Source: U.S. Census Bureau,
2010-2030 5-Year American
Community Survey Estimation
Wisconsin’s aging population and workforce
2010 2011 2012 2013 2015 2020 2025 2030
20 - 44
45 - 64
65+
Projecting Wisconsin Population by Age
21
Wisconsin’s declining per capita income
Median household income falling
$56,269
2000 2013
$51,467
Source: U.S. Census Bureau Data 22
New firms are largest drivers of America’s job creation
Source: Kaufman Foundation 23
Startups create more jobs than all other companies…
24
Source: U.S. Census Bureau; fivethirtyeight.com
… But the share of new businesses is declining
Startups as a percentage of total
25
Wisconsin ranks last for startup activity
Only 100 new ventures per 100,000 residents
50th Kauffman Foundation
2015 Ranking
Source: Kaufman Foundation 26
Wisconsin Minnesota
Population 5.7M 5.4M
Per capita income (2013) $52,413 $59,836
Gross state production (GSP) $282B $312B
Percentage of college graduates 25.6% 32.5%
Venture capital funding (2010-15) $396M $1.4B
*2015 projection from the
nonpartisan Legislative Fiscal Bureau
Sources: www.stats.indiana.edu
US Census Bureau 2014
U.S. Bureau of Economic Analysis (BEA)
27
A successful prototype . . . with room for
improvement
28
Entrepreneurs
Pillars of Wisconsin’s long-term prosperity
Innovation Enhancing our culture of entrepreneurship
Building on our high-tech research capabilities
Strengthening UW System & industry collaboration
Talent Aligning education with employers’ skill needs
Focusing on K-12 science, technology, engineering
and math (STEM)
Trade Developing strong connection to global markets
Focusing on the China, India and Brazil
Enhancing foreign direct investment
Infrastructure Modernizing our roads, bridges and rail system
Expanding broadband access statewide
Strengthening communities for economic growth
29
30